Table 2.
baseline and clinical characteristics of H1N1-pneumonia patients.
| Number | 12 |
|---|---|
| Male sex, N (%) | 8 (66 .7%) |
| Age (years) | 44.5 (36.8-48.8) |
| BMI | 27 (23.8-31) |
| SAPS II | 36 (27.75-44.75) |
| Patients with comorbidities, N (%) | 5 (41 .7%) |
| Patients with proved coinfection, N (%) | 2 (16 .7%) |
| Days from onset to ICU admission | 7 (6-8.25) |
| § PaO2(mmHg)/FiO2 | 92 (53.5-119.5) |
| § PaCO2 (mmHg) | 65 (39.9-83) |
| § pH | 7.37 (7.32-7.50) |
| § Respiratory rate (N/min) | 8.62 (6.87-11.3) |
| § White cells count (N*1000/ml) | 8.620 (6.870-11.300) |
| § Platelets count (N*1000/ml) | 158.5 (102-217.3) |
| § Lactate dehydrogenase (U/l) | 617 (391.2-919.8) |
| § Creatine kinase (U/l) | 611 (402.5-893.8) |
| § Aspartate aminotransferase (U/l) | 53.5 (39.8-121.3) |
| § Alanine aminotransferase (U/l) | 37.5 (27.3-43.5) |
| § C-reactive protein (mg/dl) | 80.5 (35.9-132.4) |
| § Serum creatinine (mg/dl) | 0.87 (0.69-1.26) |
| § Procalcitonin (ng/ml) | 3.2 (1.1-4.3) |
| Chest radiographs (mean per patient) | 7.3 |
| Chest CT-scan (mean per patient) | 1.25 |
| Tracheostomy, N (%) | 5 (41 .7%) |
| ECMO, N (%) | 7 (58 .3%) |
| CVVH, N (%) | 2 (16 .7%) |
| Duration of mechanical ventilation (days) | 13.5 (10.8-21.5) |
| ICU lenght of stay (days) | 16.5 (10.5-25.5) |
| Mortality, N (%) | 1 (8 .3%) |
Data are referred to first assessment at ICU admission. Continuous data are represented as medians with 25th to 75th interquartile range (IQR). Percent data are referred to the total population of each group.
BMI: body mass index; CVVH: continuous veno-venous hemofiltration; ECMO: extracorporeal membrane oxygenation; SAPS: simplified acute physiology score.
§ values at ICU admission